In a Phase 2a clinical trial, Columbia researchers found that the drug AEFO117 significantly reduced the effects of cannabis in daily cannabis smokers.
A Columbia study finds that adolescents who use cannabis recreationally are two to four times as likely to develop psychiatric disorders then teens who don’t use cannabis at all.
We spoke to Patrice Malone, MD, about her work with individuals struggling with psychiatric and substance use disorders, as well as her role as a director of the June Jackson Christmas Program.
In November 2021, Columbia Psychiatry stepped up as a leader in this field and named Elizabeth Ford, MD, to the newly created position of Director of Mental Health and Criminal Justice Initiatives.
We spoke to Dr. Marisa Spann about her work in early childhood psychiatry, her new role in the Office of Equity, Diversity and Inclusion, and having honest, direct conversations about race.
The Center for Practice Innovations is New York’s secret asset quietly helping to make the state’s 38,000 public sector behavioral health workforce among the best trained in the country.